Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about disclosure

27 Jan 2026 Evaluate
Nectar Lifesciences has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv Goyal & Others.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1768.00
Dr. Reddys Labs. 1340.25
Cipla 1382.00
Lupin 1996.55
Zydus Lifesciences 1239.95
View more..